ENDRA Life Sciences (NDRA) Invested Capital (2016 - 2024)

ENDRA Life Sciences (NDRA) has reported Invested Capital for 9 consecutive years, with $2.6 million the latest figure, recorded in Q4 2024.

• On a quarterly basis, Invested Capital fell 55.21% year-over-year to $2.6 million in Q4 2024; TTM through Dec 2024 was $2.6 million, a 55.21% decrease from a year earlier, with the FY2024 full-year figure at $2.6 million, down 55.21% from the prior year.
• Invested Capital was $2.6 million for Q4 2024 at ENDRA Life Sciences, down from $6.6 million in the prior quarter.
• Over five years, Invested Capital peaked at $17.9 million in Q1 2021 and troughed at $1.3 million in Q2 2020.
• A 5-year average of $8.0 million and a median of $7.3 million in 2022 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital soared 1087.6% in 2021 and slumped 55.21% in 2024, its largest moves.
• Over 5 years, Invested Capital stood at $7.8 million in 2020, then jumped by 45.67% to $11.3 million in 2021, then tumbled by 35.91% to $7.3 million in 2022, then dropped by 21.28% to $5.7 million in 2023, then tumbled by 55.21% to $2.6 million in 2024.
• The last three Invested Capital figures came in at $2.6 million (Q4 2024), $6.6 million (Q3 2024), and $9.0 million (Q2 2024), per Business Quant data.